A Dose Escalation Study of SCB01A in Subjects With Advanced Solid Tumors Who Have Failed Standard Therapy
Clinical trial NCT01159522 · COMPLETED
Trial details
- NCT number
- NCT01159522
- Sponsor
- SynCore Biotechnology Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2011-04-01
- Primary completion
- 2017-07-01
- Enrollment
- 33
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.